Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo
Zhengping Shao, Brian J. Lee, Élise Rouleau-Turcotte, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 17, pp. 9694-9709
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

XRCC1 prevents toxic PARP1 trapping during DNA base excision repair
Annie Albert Demin, Kouji Hirota, Masataka Tsuda, et al.
Molecular Cell (2021) Vol. 81, Iss. 14, pp. 3018-3030.e5
Open Access | Times Cited: 144
The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin
Dragomir B. Krastev, Shudong Li, Yilun Sun, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 1, pp. 62-73
Open Access | Times Cited: 112
ADP-ribosylation from molecular mechanisms to therapeutic implications
Marcin J. Suskiewicz, Evgeniia Prokhorova, J.G.M. Rack, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4475-4495
Open Access | Times Cited: 72
HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage
Rebecca Smith, Siham Zentout, Magdalena B. Rother, et al.
Nature Structural & Molecular Biology (2023) Vol. 30, Iss. 5, pp. 678-691
Open Access | Times Cited: 45
Rapid Detection and Signaling of DNA Damage by PARP-1
Nootan Pandey, Ben E. Black
Trends in Biochemical Sciences (2021) Vol. 46, Iss. 9, pp. 744-757
Open Access | Times Cited: 88
Serine-linked PARP1 auto-modification controls PARP inhibitor response
Evgeniia Prokhorova, Florian Zobel, Rebecca Smith, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 76
The BRCT domain of PARP1 binds intact DNA and mediates intrastrand transfer
Johannes Rudolph, Uma M. Muthurajan, Megan Palacio, et al.
Molecular Cell (2021) Vol. 81, Iss. 24, pp. 4994-5006.e5
Open Access | Times Cited: 72
PARP1: Structural insights and pharmacological targets for inhibition
Jacob O. Spiegel, Bennett Van Houten, Jacob D. Durrant
DNA repair (2021) Vol. 103, pp. 103125-103125
Open Access | Times Cited: 63
Captured snapshots of PARP1 in the active state reveal the mechanics of PARP1 allostery
Élise Rouleau-Turcotte, Dragomir B. Krastev, Stephen J. Pettitt, et al.
Molecular Cell (2022) Vol. 82, Iss. 16, pp. 2939-2951.e5
Open Access | Times Cited: 43
PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites
Xiaohui Lin, Wenxia Jiang, Johannes Rudolph, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 7, pp. 3958-3973
Open Access | Times Cited: 41
Clinical PARP inhibitors allosterically induce PARP2 retention on DNA
Marie-France Langelier, Xiaohui Lin, Shan Zha, et al.
Science Advances (2023) Vol. 9, Iss. 12
Open Access | Times Cited: 30
PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance
Petar-Bogomil Kanev, Aleksandar Atemin, Stoyno Stoynov, et al.
Seminars in Oncology (2023) Vol. 51, Iss. 1-2, pp. 2-18
Open Access | Times Cited: 24
ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification
Élise Rouleau-Turcotte, John M. Pascal
Journal of Biological Chemistry (2023) Vol. 299, Iss. 12, pp. 105397-105397
Open Access | Times Cited: 24
A unified mechanism for PARP inhibitor-induced PARP1 chromatin retention at DNA damage sites in living cells
Petar-Bogomil Kanev, Sylvia Varhoshkova, Irina Georgieva, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114234-114234
Open Access | Times Cited: 10
Poly(ADP-Ribose) Polymerase (PARP) Inhibitors for Cancer Therapy: Advances, Challenges, and Future Directions
Denys Bondar, Yevgen Karpichev
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1269-1269
Open Access | Times Cited: 8
Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs
Johannes Rudolph, Genevieve Roberts, Karolin Luger
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 52
A two-step mechanism governing PARP1-DNA retention by PARP inhibitors
Huijun Xue, Amit Bhardwaj, Yandong Yin, et al.
Science Advances (2022) Vol. 8, Iss. 36
Open Access | Times Cited: 38
Novel diketopyrrolopyrrole NIR-II fluorophores and DDR inhibitors for in vivo chemo-photodynamic therapy of osteosarcoma
Xiaoding Cheng, Chong Zhang, Kun Shen, et al.
Chemical Engineering Journal (2022) Vol. 446, pp. 136929-136929
Closed Access | Times Cited: 30
Inactive PARP1 causes embryonic lethality and genome instability in a dominant-negative manner
Zhengping Shao, Brian J. Lee, Hanwen Zhang, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 31
Open Access | Times Cited: 17
The dynamics and regulation of PARP1 and PARP2 in response to DNA damage and during replication
Hanwen Zhang, Shan Zha
DNA repair (2024) Vol. 140, pp. 103690-103690
Closed Access | Times Cited: 8
PARP trapping is governed by the PARP inhibitor dissociation rate constant
Angelica A. Gopal, Bianca Fernandez, Justin Delano, et al.
Cell chemical biology (2024) Vol. 31, Iss. 7, pp. 1373-1382.e10
Closed Access | Times Cited: 7
DNA Double Strand Break and Response Fluorescent Assays: Choices and Interpretation
Jake Atkinson, Eva Bezak, Hien Le, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2227-2227
Open Access | Times Cited: 7
Relieving Cellular Energy Stress in Aging, Neurodegenerative, and Metabolic Diseases, SIRT1 as a Therapeutic and Promising Node
Fang Yang, Xifeng Wang, Danying Yang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 33
The potential of PARP inhibitors in targeted cancer therapy and immunotherapy
Jaromir Hunia, Karol Gawalski, Aleksandra Szredzka, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 23
Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts
Xiaohui Lin, Dipika Gupta, Alina Vaitsiankova, et al.
Molecular Cell (2024) Vol. 84, Iss. 20, pp. 3916-3931.e7
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top